(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | --258.72M | 34.09%441.08M | 115.04%95.61M | 26.51%328.94M | --44.46M | 45.75%260.01M | --178.39M |
Operating income | 258.72M | 34.09%441.08M | 115.04%95.61M | 26.51%328.94M | 44.46M | 45.75%260.01M | 178.39M |
Cost of sales | ---202.34M | -42.93%-316.43M | -112.69%-75.08M | -30.15%-221.38M | ---35.3M | -40.06%-170.1M | ---121.44M |
Operating expenses | -202.34M | -42.93%-316.43M | -112.69%-75.08M | -30.15%-221.38M | -35.3M | -40.06%-170.1M | -121.44M |
Gross profit | 56.37M | 15.90%124.65M | 124.09%20.53M | 19.62%107.55M | 9.16M | 57.88%89.91M | 56.95M |
Selling expenses | ---8.16M | 12.85%-12.53M | -22.85%-3.75M | 6.93%-14.38M | ---3.06M | -5.86%-15.45M | ---14.59M |
Administrative expenses | ---18.45M | 14.07%-27.52M | 9.92%-5.37M | -56.30%-32.03M | ---5.96M | -30.32%-20.49M | ---15.72M |
Research and development expenses | ---6.06M | 7.95%-24.25M | 36.04%-3.54M | -56.12%-26.35M | ---5.53M | -32.87%-16.88M | ---12.7M |
Impairment and provision | ---5.55M | -828.37%-9.92M | 295.42%256K | -155.50%-1.07M | ---131K | -177.84%-418K | --537K |
-Other impairment is provision | ---5.55M | -828.37%-9.92M | 295.42%256K | -155.50%-1.07M | ---131K | -177.84%-418K | --537K |
Special items of operating profit | ---7.95M | -205.73%-11.65M | 73.83%2.74M | -34.81%11.02M | --1.58M | 0.99%16.9M | --16.74M |
Operating profit | 10.21M | -13.33%38.79M | 376.84%10.88M | -16.47%44.76M | -3.93M | 71.71%53.58M | 31.21M |
Financing cost | ---1.17M | -101,300.00%-1.01M | ---1K | 99.35%-1K | ---- | -285.00%-154K | ---40K |
Earning before tax | 9.04M | -15.60%37.78M | 376.81%10.88M | -16.23%44.76M | -3.93M | 71.44%53.43M | 31.17M |
Tax | ---659K | 21.83%-2.71M | -303.36%-1.09M | 53.48%-3.47M | --535K | -89.32%-7.46M | ---3.94M |
After-tax profit from continuing operations | 8.38M | -15.07%35.06M | 388.39%9.79M | -10.19%41.28M | -3.39M | 68.85%45.97M | 27.22M |
Earning after tax | 8.38M | -15.07%35.06M | 388.39%9.79M | -10.19%41.28M | -3.39M | 68.85%45.97M | 27.22M |
Minority profit | ---269K | 785.71%310K | 977.59%509K | 177.78%35K | ---58K | -7.14%-45K | ---42K |
Profit attributable to shareholders | 8.65M | -15.75%34.75M | 378.15%9.28M | -10.35%41.25M | -3.34M | 68.75%46.01M | 27.27M |
Basic earnings per share | 0.19 | -15.38%0.77 | 385.71%0.2 | -10.78%0.91 | -0.07 | 67.21%1.02 | 0.61 |
Diluted earnings per share | 0.19 | -15.38%0.77 | 385.71%0.2 | -10.78%0.91 | -0.07 | 67.21%1.02 | 0.61 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data